Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL:

Adult stem cells reverse multiple sclerosis in UK trial

25 January 2016
Appeared in BioNews 836

A stem cell treatment routinely used for bone and blood cancers is showing promise at reversing the effects of multiple sclerosis (MS).

The treatment, known as autologous haematopoietic stem cell transplant (HSCT), uses chemotherapy to break down the patient's faulty immune system. Stem cells are then harvested and re-infused into the patient to 'reboot' their immune system. Within two weeks, new red and white blood cells start to grow.

Over two million people worldwide are affected by MS. The body's own immune system attacks and damages the myelin – the protective layer that surrounds nerve fibres. This damage impairs nerve-cell transmission in the brain and the spinal cord, causing widespread disability. Although some drugs exist to help with early symptoms of the disease, there is currently no cure.

'There has been resistance to this in the pharma and academic world. This is not a technology you can patent and we have achieved this without industry backing,' Professor Richard Burt of Northwestern University in Chicago told the BBC.

This past week, the BBC documentary Panorama was given access to some of the patients treated with HSCT in a trial at the Royal Hallamshire Hospital in Sheffield.

These include Holly Dewry, who was diagnosed with MS at the age of 21. 'Within a couple of months I got worse and worse. I couldn't dress or wash myself; I didn't even have the strength to carry my daughter,' she said in the documentary.

Holly needed a wheelchair before her transplant, but after the treatment she walked out of hospital. 'It's been a miracle. I got my life and my independence back, and the future is bright again.'

Two years on she has suffered no relapses and there is no evidence of active disease on her scans.

'Ongoing research suggests stem cell treatments such as HSCT could offer hope, and it's clear that in the cases highlighted by Panorama they've had a life-changing impact,' Dr Emma Gray, head of clinical trials at UK's Multiple Sclerosis Society, told the BBC.

So far only around 20 patients have been treated with the technique for MS, but the results have been called miraculous. 'This is not a word I would use lightly, but we have seen profound neurological improvements,' Professor Basil Sharrack, a consultant neurologist at Sheffield Teaching Hospital's NHS Foundation Trust, told the Telegraph.

Doctors involved in the research stress that the treatment may not suitable to everyone with MS and results, though encouraging, are still preliminary.

The trial now aims to assess the long-term benefits of the stem cell transplant for MS. It includes patients with relapsing, remitting MS, which involves flare-ups of symptoms that can last from days to months. The international trial is being conducted at Sheffield as well as hospitals in the US, Sweden and Brazil.

Cancer treatment for MS patients gives 'remarkable' results
BBC News |  18 January 2016
Cancer treatment offers MS patients hope after 'remarkable' trial results
The Guardian |  18 January 2016
Can You Stop My Multiple Sclerosis?
BBC Panorama |  18 January 2016
Ground breaking treatment for MS features on Panorama
Sheffield Teaching Hospitals (press release) |  18 January 2016
'Miraculous' results from new MS treatment
The Telegraph |  18 January 2016
27 November 2017 - by Ewa Zotow 
Paraplegic rats were able to walk after being treated with human stem cells. This is the first time lower body movement has been restored after an animal's spinal cord has been completely severed...
25 September 2017 - by Sarah Gregory 
A novel gene therapy can reverse the symptoms and progression of disease in a mouse model of multiple sclerosis...
27 February 2017 - by Jamie Rickman 
A study has demonstrated that a new, one-off stem cell treatment for multiple sclerosis can 'freeze' progression of the disease for five years in some patients...
25 April 2016 - by Dr Julia Hill 
A study has found that stem cells from older people accumulate high numbers of mitochondrial DNA mutations, which could limit their therapeutic value...
7 September 2015 - by Ari Haque 
A woman in the USA who acted as a surrogate for her daughter has given birth to her biological granddaughter...
1 September 2015 - by Lubna Ahmed 
A recent study by researchers in Canada has found that people who are genetically susceptible to low vitamin-D levels are at a higher risk of multiple sclerosis...
26 January 2015 - by Dr Tamara Hirsch 
An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis has demonstrated neurological improvement and enhanced quality of life for patients...
9 June 2014 - by Isobel Steer 
Human embryonic stem cells have been shown to be more effective in treating multiple sclerosis (MS) in mice than bone marrow stem cells, a study has found...
19 May 2014 - by Alice Plein 
Mice with a viral form of multiple sclerosis are able to walk again after receiving a transplant of human stem cells, scientists report...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.